Jean P. Salles
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
French national diagnosis and care protocol (PNDS) for infantile idiopathic hypercalcemia (IIH).
Journal: Orphanet journal of rare diseases
Published: April 10, 2025
Oral Infigratinib Therapy in Children with Achondroplasia.
Journal: The New England journal of medicine
Published: November 18, 2024
Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.
Journal: European journal of endocrinology
Published: April 21, 2023
Diagnostic yield of bone fragility gene panel sequencing in children and young adults referred for idiopathic primary osteoporosis at a single regional reference centre.
Journal: Bone reports
Published: February 18, 2022
Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies.
Journal: Therapeutic advances in musculoskeletal disease
Published: December 22, 2021
WNT11, a new gene associated with early onset osteoporosis, is required for osteoblastogenesis.
Journal: Human molecular genetics
Published: September 13, 2021
Hypophosphatasia: A Case of Two Patients With Spinal Cord Compression From Increase in Ligamentous Ossifications During Treatment.
Journal: JBMR plus
Published: October 13, 2020
SNORD116 and growth hormone therapy impact IGFBP7 in Prader-Willi syndrome.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 25, 2020
Ghrelin uses the GHS-R1a/Gi/cAMP pathway and induces differentiation only in mature osteoblasts. This ghrelin pathway is impaired in AIS patients.
Journal: Biochemistry and biophysics reports
Published: April 24, 2020
Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.
Journal: The Clinical biochemist. Reviews
Published: March 12, 2020
Endospanin-2 enhances skeletal muscle energy metabolism and running endurance capacity.
Journal: JCI insight
Published: October 13, 2017
Induced pluripotent stem cells (iPSC) created from skin fibroblasts of patients with Prader-Willi syndrome (PWS) retain the molecular signature of PWS.
Journal: Stem cell research
Published: August 09, 2016
Last Updated: 09/26/2026